Search research articles
Contact Us
Filters
Showing results (1-10 of 46) with videos related to
Page
of 5
Sort By:
Molecular Membrane Biology
|
August 23, 2013
Expression, characterization and ligand specificity of lipocalin-1 interacting membrane receptor (LIMR)
Renske W Hesselink, John B C Findlay
Biochimica Et Biophysica Acta
|
October 24, 2012
The melanocortin 4 receptor: oligomer formation, interaction sites and functional significance
Kathryn L Chapman, John B C Findlay
Novartis Foundation Symposium
|
May 25, 2002
A protein chemical approach to channel structure and function: the proton channel of the vacuolar H(+)-ATPase
John B C Findlay, Michael A Harrison
European Journal of Pharmacology
|
January 16, 2017
The signalling mechanisms of a novel mitochondrial complex I inhibitor prevent lipid accumulation and attenuate TNF-α-induced insulin resistance in vitro
Siobhán Leonard, Laura M Tobin, John B C Findlay
Diabetes & Vascular Disease Research
|
November 25, 2005
The application of proteomics to diabetes
Eleanor M Scott, Angela M Carter, John B C Findlay
Biochimica Et Biophysica Acta
|
December 4, 2003
Expression, purification and spectroscopic studies of full-length Kir3.1 channel C-terminus
Robert N Leach, Mark R Boyett, John B C Findlay
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
November 10, 2007
Identification of the retinol-binding protein (RBP) interaction site and functional state of RBPs for the membrane receptor
Clara Redondo, Maria Vouropoulou, Jonathan Evans, et al.
The Biochemical Journal
|
September 5, 2002
Topological analysis of peripherin/rds and abnormal glycosylation of the pathogenic Pro216-->Leu mutation
Jonathan D J Wrigley, Claire L Nevett, John B C Findlay
Biochemical Society Transactions
|
July 24, 2012
Pharmacological chaperones increase the cell-surface expression of intracellularly retained mutants of the melanocortin 4 receptor with unique rescuing efficacy profiles
Natalie-Anne Ward, Simon Hirst, John Williams, et al.
Scientific Reports
|
June 1, 2016
Regulating the effects of GPR21, a novel target for type 2 diabetes
Siobhán Leonard, Gemma K Kinsella, Elisa Benetti, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 46) with videos related to
Sort By:
Page
of 5
Molecular Membrane Biology
|
August 23, 2013
Expression, characterization and ligand specificity of lipocalin-1 interacting membrane receptor (LIMR)
Renske W Hesselink, John B C Findlay
Biochimica Et Biophysica Acta
|
October 24, 2012
The melanocortin 4 receptor: oligomer formation, interaction sites and functional significance
Kathryn L Chapman, John B C Findlay
Novartis Foundation Symposium
|
May 25, 2002
A protein chemical approach to channel structure and function: the proton channel of the vacuolar H(+)-ATPase
John B C Findlay, Michael A Harrison
European Journal of Pharmacology
|
January 16, 2017
The signalling mechanisms of a novel mitochondrial complex I inhibitor prevent lipid accumulation and attenuate TNF-α-induced insulin resistance in vitro
Siobhán Leonard, Laura M Tobin, John B C Findlay
Diabetes & Vascular Disease Research
|
November 25, 2005
The application of proteomics to diabetes
Eleanor M Scott, Angela M Carter, John B C Findlay
Biochimica Et Biophysica Acta
|
December 4, 2003
Expression, purification and spectroscopic studies of full-length Kir3.1 channel C-terminus
Robert N Leach, Mark R Boyett, John B C Findlay
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
November 10, 2007
Identification of the retinol-binding protein (RBP) interaction site and functional state of RBPs for the membrane receptor
Clara Redondo, Maria Vouropoulou, Jonathan Evans, et al.
The Biochemical Journal
|
September 5, 2002
Topological analysis of peripherin/rds and abnormal glycosylation of the pathogenic Pro216-->Leu mutation
Jonathan D J Wrigley, Claire L Nevett, John B C Findlay
Biochemical Society Transactions
|
July 24, 2012
Pharmacological chaperones increase the cell-surface expression of intracellularly retained mutants of the melanocortin 4 receptor with unique rescuing efficacy profiles
Natalie-Anne Ward, Simon Hirst, John Williams, et al.
Scientific Reports
|
June 1, 2016
Regulating the effects of GPR21, a novel target for type 2 diabetes
Siobhán Leonard, Gemma K Kinsella, Elisa Benetti, et al.
Page
of 5